莫妥珠单抗
Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A; R07030816;CD20-TDB; RG7828; CD20 CD3 bispecific antibody.)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A; R07030816;CD20-TDB; RG7828; CD20 CD3 bispecific antibody.)
CAS1905409-39-3
Storage conditionstore at -20°C
Security information
Product details

Mosunetuzumab is a humanized bispecific antibody that targets CD20 on B cells and CD3 on T cells, redirecting T-cell cytotoxicity to kill malignant B cells. This IgG1 TDB antibody is being studied for treating relapsed/refractory B-cell non-Hodgkin lymphomas.


Related
Sorry, no related items
History
CY3 (Sulfo-Cyanine3); Sulfo-Cyanine3 Carboxlylic Acid; Sulfo-Cy3-COOH; Sulfo-CY3 Carboxylic Acid
Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A; R07030816;CD20-TDB; RG7828; CD20 CD3 bispecific antibody.)
Indobufen
(Z)-Orantinib | (Z)-SU6668 | (Z)-TSU-68
S-2-(aMinoMethyl)-1-n-boc-pyrrolidine-HCl
Ruxolitinib | INCB018424 | Ruxolitinib Free base | (R)-Ruxolitinib
Fludarabine | Fara A | Fludarabinum | Fludarabine | F-ara-A | NSC 118218 Base
Brigimadlin (Synonyms: BI 907828)
Tigecycline tetramesylate | GAR-936 tetramesylate
Givinostat (Synonyms: ITF-2357)